1. The induction of the plasminogen activator system during phorbol ester (PMA)-induced differentiation in HL-60 leukemic cells
   A.J. Gruneiro et al, 1995, Fibrinolysis CrossRef
2. Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)
   O. Wilhelm et al, 1994, FEBS Letters CrossRef
3. Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice
   Olaf Wilhelm et al, 1995, Clinical & Experimental Metastasis CrossRef
4. HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
   Tamara Mirzapoiazova et al, 2015, Frontiers in Oncology CrossRef
5. Urokinasetyp-Plasminogenaktivator (uPA), sein Inhibitor PAI-1 und sein Rezeptor (CD87) sind an Tumorinvasion und Metastasierung solider maligner Tumoren beteiligt
   M. Schmitt et al, 1996, Malignome und Hämostase CrossRef
6. Urokinase‐Type Plasminogen Activator (uPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis
   Manfred Schmitt et al, 1995, Journal of Obstetrics and Gynaecology CrossRef
7. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function
   Kerstin Fischer et al, 1998, FEBS Letters CrossRef